SGHT — Sight Sciences Share News
0.000.00%
Last trade - 00:00- $287.28m
- $242.86m
- $77.36m
Brief: Sight Sciences Q1 Revenue USD 19.7 Million Vs. IBES Estimate USD 18.5 Million
Brief: Sight Sciences U.S. District Court Issued Order On Post-Trial Motions In Patent Infringement Case Against Alcon Originally Filed On Sep 16, 2021
Sight Sciences Q4 revenue rises 7%
Brief: Sight Sciences Announces Preliminary, Unaudited Fourth Quarter And Full Year 2025 Financial Highlights
U.S. STOCKS ON THE MOVE-Synchrony Financial, Coinbase, Versant Media Group
U.S. STOCKS ON THE MOVE-Qualcomm, Costco, Topgolf Callaway Brands
U.S. STOCKS ON THE MOVE-Alphabet, Liberty Energy, Fortive
Piper Sandler upgrades Sight Sciences on strong business prospects
Brief: Sight Sciences Inc - Has Exposure To Tariffs Imposed By The U.S. On China Because Most Of Its Products Are Produced And Assembled In China
Sight Sciences Q3 revenue beats expectations, raises 2025 guidance
Brief: Sight Sciences Q3 Revenue USD 19.9 Million Vs. IBES Estimate USD 17.7 Million
Brief: Sight Sciences Says Available Draw Increased To $25 Million Under Amendment - SEC Filing
Brief: Sight Sciences Announces OMNI Surgical System To Be Included In UnitedHealthcare's Expanded Coverage Of Glaucoma Surgical Treatments
Brief: Sight Sciences Inc To Cut 20% Of Global Workforce
Sight Sciences Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Sight Sciences Q2 Revenue USD 19.6 Million Vs. IBES Estimate USD 18.2 Million
Sight Sciences Inc expected to post a loss of 26 cents a share - Earnings Preview
Sight Sciences Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Sight Sciences Q1 Revenue USD 17.5 Million Vs. IBES Estimate USD 16.5 Million